 | • レポートコード：TPM-2JN059 • 出版社/出版日：Transparency Market Research / 2019年12月31日 • レポート形態：英文、PDF、246ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは神経刺激装置の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場動向、キーインサイト、種類別分析、容量別分析、エンドユーザー別分析、地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場動向 ・神経刺激装置の世界市場：キーインサイト ・神経刺激装置の世界市場：製品別 ・神経刺激装置の世界市場：用途別 ・神経刺激装置の世界市場：エンドユーザー別 ・神経刺激装置の世界市場：地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ） ・神経刺激装置の北米市場分析・予測 ・神経刺激装置の欧州市場分析・予測 ・神経刺激装置のアジア太平洋市場分析・予測 ・神経刺激装置の中南米市場分析・予測 ・神経刺激装置の中東・アフリカ市場分析・予測 ・競争状況 |
Design innovations improve the manufacturability of neurostimulation devices. Companies in the neurostimulation devices market are developing new lead interfaces to integrate new external pulse generators. Apart from chronic pain and epilepsy, healthcare industries are increasing awareness about neurostimulation devices for the treatment of bladder dysfunction. Technological developments in devices are benefitting stakeholders in the healthcare value chain with the increasing availability of new and improved solutions.
The trend of implantable neurostimulation technologies is driving the growth of the neurostimulation devices market. Companies are exploring untapped opportunities in the development of new lead interfaces in external pulse generators. Innovations in new lead interfaces are overcoming the drawbacks of conventional lead interface designs. Clinical challenges associated with traditional lead interface designs are triggering the demand for new lead interfaces.
By streamlining production processes, medical hardware manufacturers in the neurostimulation devices market can significantly reduce the time required to develop these devices. They should adopt techniques of laser welding and other high-precision techniques to optimize lead interface designs.
The trend of smart neuromodulation is engulfing the neurostimulation devices market. Better understanding of neural targets with AI is paving the way for technological advancements. Companies in the neurostimulation devices space are harnessing the techniques of machine learning to assess non-invasive brain computer interfaces. These techniques are creating scope for treatment opportunities catering to brain damage.
Companies in the neurostimulation devices market are increasing research efforts in understanding brain functions and AI to overcome stagnation in neuromodulation technology. To sustain success in the landscape, healthcare industries will have to incorporate neurophilosophy of network science, since brain functions are complex and complicated. Neurophilosophy of network science is helping companies deploy novel stimulation designs such as burst stimulation. The new technique of burst stimulation is incorporated with sensing technology to record brain activity and generate key insights. Closed-loop spinal cord stimulation serves as an efficacious treatment option for chronic pain. On the other hand, companies are running several clinical trials to assess the effects of responsive brain stimulation for epilepsy.
Healthcare providers are increasing efforts to achieve increased success rate in brain implants. The implantation of neurostimulation devices in Parkinson’s patients is creating a scope for incremental opportunities for companies in the neurostimulation devices market. Currently, epilepsy accounts for the third-highest revenue amongst all applications in the neurostimulation devices market, with a recorded value of ~US$ 750 million in 2018. Smart implants are helping treat epilepsy and other neurological conditions such as Parkinson’s disease, as these implants ‘listen’ to brain signals and stimulate brain activity.
Neurostimulation devices are being increasingly used to treat various health conditions, such as the effects of stroke and even depression, amongst patients. Healthcare companies are increasing research to develop tiny external controllers that monitor any abnormal activity in the brain. Novel neurostimulation devices can modulate electrical signals to prevent the incidence of seizure or tremors in patients. Neurostimulation devices are gaining increased popularity amongst individuals, owning to their cost-efficiency and time effectiveness attributes. More and more individuals are benefitting with the help of neurostimulation devices, as the effectiveness of these devices saves time and money to find the right therapy for patients.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neurostimulation Devices Market
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurostimulation Devices Market Value (US$ Mn) and Volume (Units) Forecast, 2017–2027
5. Global Neurostimulation Devices Market, Key Insights
5.1. Disease Prevalence: Chronic Pain, Parkinson’s Disease, Epilepsy, Urinary Incontinence
5.2. Technological Advancements and New Product Launches
6. Global Neurostimulation Devices Market Analysis and Forecast, by Product
6.1. Introduction
6.2. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019–2027
6.2.1. Spinal Cord Stimulators
6.2.2. Deep Brain Stimulators
6.2.3. Cochlear Implants
6.2.4. Vagus Nerve Stimulators
6.2.5. Sacral Nerve Stimulators
6.2.6. Percutaneous Tibial Nerve Stimulators
6.2.7. Transcranial Magnetic Stimulation
6.3. Market Attractiveness Analysis, by Product
7. Global Neurostimulation Devices Market Analysis and Forecast, by Application
7.1. Introduction
7.2. Market Value (US$ Mn) Forecast, by Application, 2019–2027
7.2.1. Chronic Pain
7.2.2. Movement Disorders
7.2.3. Hearing Impairment
7.2.4. Epilepsy
7.2.5. Urinary Incontinence
7.2.6. Major Depressive Disorders
7.3. Market Attractiveness Analysis, by Application
8. Global Neurostimulation Devices Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Market Value (US$ Mn) Forecast, by End-user, 2019–2027
8.2.1. Hospitals
8.2.2. Ambulatory Surgery Centers
8.2.3. Specialty Clinics
8.3. Market Attractiveness Analysis, by End-user
9. Global Neurostimulation Devices Market Analysis and Forecast, by Region
9.1. Global Market Scenario
9.2. Market Value (US$ Mn) Forecast, by Region, 2019–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Neurostimulation Devices Market Analysis and Forecast
10.1. Market Overview
10.2. Market Value (US$ Mn) Forecast, by Country, 2019–2027
10.2.1. U.S.
10.2.2. Canada
10.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019–2027
10.3.1. Spinal Cord Stimulators
10.3.2. Deep Brain Stimulators
10.3.3. Cochlear Implants
10.3.4. Vagus Nerve Stimulators
10.3.5. Sacral Nerve Stimulators
10.3.6. Percutaneous Tibial Nerve Stimulators
10.3.7. Transcranial Magnetic Stimulation
10.4. Market Value (US$ Mn) Forecast, by Application, 2019–2027
10.4.1. Chronic Pain
10.4.2. Movement Disorders
10.4.3. Hearing Impairment
10.4.4. Epilepsy
10.4.5. Urinary Incontinence
10.4.6. Major Depressive Disorders
10.5. Market Value (US$ Mn) Forecast, by End-user, 2019–2027
10.5.1. Hospitals
10.5.2. Ambulatory Surgery Centers
10.5.3. Specialty Clinics
10.6. Market Attractiveness Analysis
10.6.1. By Country
10.6.2. By Product
10.6.3. By Application
10.6.4. By End-user
11. Europe Neurostimulation Devices Market Analysis and Forecast
11.1. Market Overview
11.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
11.2.1. Germany
11.2.2. U.K.
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019–2027
11.3.1. Spinal Cord Stimulators
11.3.2. Deep Brain Stimulators
11.3.3. Cochlear Implants
11.3.4. Vagus Nerve Stimulators
11.3.5. Sacral Nerve Stimulators
11.3.6. Percutaneous Tibial Nerve Stimulators
11.3.7. Transcranial Magnetic Stimulation
11.4. Market Value (US$ Mn) Forecast, by Application, 2019–2027
11.4.1. Chronic Pain
11.4.2. Movement Disorders
11.4.3. Hearing Impairment
11.4.4. Epilepsy
11.4.5. Urinary Incontinence
11.4.6. Major Depressive Disorders
11.5. Market Value (US$ Mn) Forecast, by End-user, 2019–2027
11.5.1. Hospitals
11.5.2. Ambulatory Surgery Centers
11.5.3. Specialty Clinics
11.6. Market Attractiveness Analysis
11.6.1. By Country/Sub-region
11.6.2. By Product
11.6.3. By Application
11.6.4. By End-user
12. Asia Pacific Neurostimulation Devices Market Analysis and Forecast
12.1. Market Overview
12.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
12.2.1. China
12.2.2. India
12.2.3. Japan
12.2.4. Australia & New Zealand
12.2.5. Rest of Asia Pacific
12.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019–2027
12.3.1. Spinal Cord Stimulators
12.3.2. Deep Brain Stimulators
12.3.3. Cochlear Implants
12.3.4. Vagus Nerve Stimulators
12.3.5. Sacral Nerve Stimulators
12.3.6. Percutaneous Tibial Nerve Stimulators
12.3.7. Transcranial Magnetic Stimulation
12.4. Market Value (US$ Mn) Forecast, by Application, 2019–2027
12.4.1. Chronic Pain
12.4.2. Movement Disorders
12.4.3. Hearing Impairment
12.4.4. Epilepsy
12.4.5. Urinary Incontinence
12.4.6. Major Depressive Disorders
12.5. Market Value (US$ Mn) Forecast, by End-user, 2019–2027
12.5.1. Hospitals
12.5.2. Ambulatory Surgery Centers
12.5.3. Specialty Clinics
12.6. Market Attractiveness Analysis
12.6.1. By Country/Sub-region
12.6.2. By Product
12.6.3. By Application
12.6.4. By End-user
13. Latin America Neurostimulation Devices Market Analysis and Forecast
13.1. Market Overview
13.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
13.2.1. Brazil
13.2.2. Mexico
13.2.3. Rest of Latin America
13.3. Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2019–2027
13.3.1. Spinal Cord Stimulators
13.3.2. Deep Brain Stimulators
13.3.3. Cochlear Implants
13.3.4. Vagus Nerve Stimulators
13.3.5. Sacral Nerve Stimulators
13.3.6. Percutaneous Tibial Nerve Stimulators
13.3.7. Transcranial Magnetic Stimulation
13.4. Market Value (US$ Mn) Forecast, by Application, 2019–2027
13.4.1. Chronic Pain
13.4.2. Movement Disorders
13.4.3. Hearing Impairment
13.4.4. Epilepsy
13.4.5. Urinary Incontinence
13.4.6. Major Depressive Disorders
13.5. Market Value (US$ Mn) Forecast, by End-user, 2019–2027
13.5.1. Hospitals
13.5.2. Ambulatory Surgery Centers
13.5.3. Specialty Clinics
13.6. Market Attractiveness Analysis
13.6.1. By Country/Sub-region
13.6.2. By Product
13.6.3. By Application
13.6.4. By End-user
14. Middle East and Africa Neurostimulation Devices Market Analysis and Forecast
14.1. Market Overview
14.2. Market Value (US$ Mn) Forecast, by Country/Sub-region, 2019–2027
14.2.1. GCC Countries
14.2.2. South Africa
14.2.3. Rest of Middle East and Africa
14.3. Market Value (US$ Mn) Forecast, by Product, 2019–2027
14.3.1. Spinal Cord Stimulators
14.3.2. Deep Brain Stimulators
14.3.3. Cochlear Implants
14.3.4. Vagus Nerve Stimulators
14.3.5. Sacral Nerve Stimulators
14.3.6. Percutaneous Tibial Nerve Stimulators
14.3.7. Transcranial Magnetic Stimulation
14.4. Market Value (US$ Mn) Forecast, by Application, 2019–2027
14.4.1. Chronic Pain
14.4.2. Movement Disorders
14.4.3. Hearing Impairment
14.4.4. Epilepsy
14.4.5. Urinary Incontinence
14.4.6. Major Depressive Disorders
14.5. Market Value (US$ Mn) Forecast, by End-user, 2019–2027
14.5.1. Hospitals
14.5.2. Ambulatory Surgery Centers
14.5.3. Specialty Clinics
14.6. Market Attractiveness Analysis
14.6.1. By Country/Sub-region
14.6.2. By Product
14.6.3. By Application
14.6.4. By End-user
15. Competition Landscape
15.1. Global Neurostimulation Devices Market Share, by Company, 2018
15.2. Market Player – Competition Matrix (By Tier and Size of companies)
15.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.3.1. Boston Scientific Corporation
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Medtronic plc
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Nevro Corp
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. LivaNova PLC
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Axonics Modulation Technologies, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Neuropace, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. EndoStim, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. NDI Medical
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Cochlear Limited
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Neuronetics, Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
List of TablesTable 01: Global Neurostimulation Devices Market Size (US$ Mn) Forecast, by Product, 2017 - 2027
Table 02: Global Neurostimulation Devices Market Volume (Units) Forecast, by Product, 2017 - 2027
Table 03: Global Neurostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017 - 2027
Table 04: Global Neurostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 05: Global Neurostimulation Devices Market Size (US$ Mn) Forecast, by Region, 2017 - 2027
Table 06: North America Neurostimulation Devices Market Size (US$ Mn) Forecast, by Country, 2017 - 2027
Table 07: North America Neurostimulation Devices Market Size (US$ Mn) Forecast, by Product, 2017 - 2027
Table 08: North America Neurostimulation Devices Market Volume (Units) Forecast, by Product, 2017 - 2027
Table 09: North America Neurostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017 - 2027
Table 10: North America Neurostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 11: Europe Neurostimulation Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 12: Europe Neurostimulation Devices Market Size (US$ Mn) Forecast, by Product, 2017 - 2027
Table 13: Europe Neurostimulation Devices Market Volume (Units) Forecast, by Product, 2017 - 2027
Table 14: Europe Neurostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017 - 2027
Table 15: Europe Neurostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 16: Asia Pacific Neurostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 17: Asia Pacific Neurostimulation Devices Market Size (US$ Mn) Forecast, by Product, 2017 - 2027
Table 18: Asia Pacific Neurostimulation Devices Market Volume (Units) Forecast, by Product, 2017 - 2027
Table 19: Asia Pacific Neurostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017 - 2027
Table 20: Asia Pacific Neurostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 21: Latin America Neurostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 22: Latin America Neurostimulation Devices Market Size (US$ Mn) Forecast, by Product, 2017 - 2027
Table 23: Latin America Neurostimulation Devices Market Volume (Units) Forecast, by Product, 2017 - 2027
Table 24: Latin America Neurostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017 - 2027
Table 25: Latin America Neurostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017 - 2027
Table 26: Middle East & Africa Neurostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
Table 27: Middle East & Africa Neurostimulation Devices Market Size (US$ Mn) Forecast, by Product, 2017 - 2027
Table 28: Middle East & Africa Neurostimulation Devices Market Volume (Units) Forecast, by Product, 2017 - 2027
Table 29: Middle East & Africa Neurostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017 - 2027
Table 30: Middle East & Africa Neurostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017 - 2027